Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-018-0 | CAS number: 50-21-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Additional toxicological data
Administrative data
- Endpoint:
- additional toxicological information
- Type of information:
- other: expert statement
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- This is a custom literature review on the biology and (non)toxicity of D-(-)-lactic acid.
- Justification for type of information:
- Statement explaining why no further toxicity testing with lactic acid is required. This statement supports the submission of the available toxicity information for Lactic acid for classification and labelling of D-(-)-lactic acid, and consequently general lactic acid.
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Literature review
- GLP compliance:
- no
Test material
- Reference substance name:
- Lactic acid
- EC Number:
- 200-018-0
- EC Name:
- Lactic acid
- Cas Number:
- 50-21-5
- Molecular formula:
- C3H6O3
- IUPAC Name:
- 2-hydroxypropanoic acid
Constituent 1
Results and discussion
Any other information on results incl. tables
D-(-)-lactic acid is a common biological molecule, with low acute and no chronic toxicity, to which humans are continuoualy exposed, from diet, from bacterial generation in the gut, and from intramitochondrial (innate) processes.
Background exposure to D-(-)-lactic acid:
Lactic acid is normally present in human urine. A rough estimate suggests that the daily excretion reaches about 10 mg, which amounts to about 25% of the total amount of lactic acid. Excretion increases upon physical excercise, although the excretion of LL increases much more in absolute terms.
Small amounts of lactic acid are normally present in human blood. One study pointed to a 1.1-3.4 fold increase in the blood concentration of lactic acid due to eating or exercise. A rough indication of the range of the total amount is 3 – 25 mg per person. This range underlines the constant systemic exposure of the non-diseased population.
One study shows that in faeces from non-diseased persons lactic acid concentrations are very low (0 – 0.1 mmol/L). However the studies by Hove consistently point to higher concentrations (1.9 mmol/L).
Presence in the diet:
Dietary exposure of humans to lactic acid can occur when food products and beverages that have undergone lactic acid fermentation are consumed. Notable examples are regular yoghurt, sauerkraut, and wine. A 100 mL serving (small beaker) of regular yoghurt may contain up to 600 mg of lactic acid. Additional dairy sources are cheeses and kefir. A glass of wine may contain up to 160 mg of lactic acid. A moderate consumption of both yoghurt and wine may already result in a daily intake of 1 g lactic acid.
Metabolism:
Lactic acid is formed in the human body by:
· Fermentation of carbohydrates by anaerobic bacteria in the colon. Although lactic acid is largely converted further into short chain fatty acid, a low but significant steady state concentration results.
· The detoxification of methylglyoxal by the glyoxalase system in the cytosol and in the mitochondria. The omnipresence of this system in living organisms as well as the adverse effects associated with its inhibition or lack of capacity, strongly suggests that lactic acid is formed throughout the body in the healthy individual.
Biokinetics:
The biokinetics of lactic acid is characterized by rapid and complete absorption and rapid elimination, largely by oxidation to pyruvate in the mitochondra, and to a lesser extent by urinary excretion. The importance of urinary excretion increases upon higher dose levels. D-(-)-lactic acid biokinetics thus resembles L-(+)-lactic acid to the extent that it is not expected to result in a difference in toxicity between the two enantiomers. The old idea that humans could not metabolize/utilize D-(-)-lactic acid and that the compound is not ‘physiological’ has been superseded by the notion of efficient utilization and the recognition that the compound should be regarded as fully ‘physiological’.
Overall conclusions:
- Natural exposure of humans and occurrence in humans of D-(-)-lactic acid make repeated-dose toxicity testing with this substance in the context of REACH redundant.
- Biokinetics indicates that the fact that D-(-)-lactic acid is a stereoisomer of L(+)-lactic acid does not preclude the use of toxicity data obtained with L(+)-lactic acid.
- D-(-)-lactic acid acidosis bears no relevance to the context of REACH.
Please refer to the attachment for the entire expert statement.
Applicant's summary and conclusion
- Conclusions:
- D-(-)-lactic acid is a common biological molecule, with low acute and no chronic toxicity, to which humans are continuously exposed, from diet, from bacterial generation in the gut, and from intramitochondrial (innate) processes.
- Executive summary:
D-(-)-lactic acid is a common biological molecule, with low acute and no chronic toxicity, to which humans are continuously exposed, from diet, from bacterial generation in the gut, and from intramitochondrial (innate) processes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.